Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes

• Main Authors: Yuan Zou (Author), Jing Zhang (Author), Fei Sun (Author), Qianqian Xu (Author), Longmin Chen (Author), Xi Luo (Author), Ting Wang (Author), Qing Zhou (Author), Shu Zhang (Author), Fei Xiong (Author), Wen Kong (Author), Ping Yang (Author), Qilin Yu (Author), Shiwei Liu (Author), Cong-Yi Wang (Author)
• Format: Book
• Published: BMC, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Fluvoxamine is one of the selective serotonin reuptake inhibitors (SSRIs) that are regarded as the first-line drugs to manage mental disorders. It has been also recognized with the potential to treat inflammatory diseases and viral infection. However, the effect of fluvoxamine on...